Michael D. Ezekowitz

Author

Also Known As

Ezekowitz MD, For the PASCAL Investigators, M D Ezekowitz, M EZEKOWITZ, M Ezekowitz, M. D. EZEKOWITZ, M. D. Ezekowitz, M. Ezekowitz, M. P. Van Den Berg, M.D. EZEKOWITZ

377

Publications

72.5K

Citations

H-Index

117

Concepts

All Affiliations

Uppsala University Population Health Research Institute Lankenau Institute for Medical Research McMaster University Yale University

About

Michael D. Ezekowitz is an author at Uppsala University specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	48	89	23.9K
2	Public Health	34	58	20.9K
3	Health Sciences	5	5	674
4	Engineering	2	2	49
5	Social Sciences	1	1	112

Michael D. Ezekowitz

183

Publications

52.2K

Citations

H-Index

Page 1

	Year	Citations
Dabigatran versus Warfarin in Patients with Atrial Fibrillation Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf, New England Journal of Medicine	2009	11.1K
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack Walter N. Kernan, Bruce Ovbiagele, Henry R. Black, Stroke Cerebrovascular DiseaseUpdated GuidelineThrombosisStroke RehabilitationStroke	2014	5.2K
Forecasting the Future of Cardiovascular Disease in the United States Paul A. Heidenreich, Justin G. Trogdon, Olga Khavjou, Circulation	2011	3.2K
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation Craig T. January, L. Samüel Wann, Joseph S. Alpert, Journal of the American College of Cardiology ThrombosisElectrophysiological EvaluationCardiovascular DiseasePatient SafetyCardiovascular Pharmacology	2014	3K
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation Craig T. January, L. Samüel Wann, Hugh Calkins, Journal of the American College of Cardiology ThrombosisElectrophysiological EvaluationCardiovascular DiseasePatient SafetyAha/acc/hrs Guideline	2019	2.2K
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary Craig T. January, L. Samüel Wann, Joseph S. Alpert, Circulation ThrombosisCardiovascular DiseasePatient SafetyAha/acc/hrs GuidelineCardiac Care	2014	2K
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design Hugh Calkins, Riccardo Cappato, Josép Brugada, Heart Rhythm	2012	1.5K
2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline) L. Samüel Wann, Anne B. Curtis, Craig T. January, Circulation ThrombosisElectrophysiological EvaluationCardiovascular DiseasePatient SafetyCardiac Care	2010	1.3K
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation Michael D. Ezekowitz, Samuel L. Bridgers, K James, New England Journal of Medicine	1992	1.2K
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial Lars Wallentin, Salim Yusuf, Michael D. Ezekowitz, The Lancet ThrombosisVenous ThrombosisCardiovascular DiseaseStrokeRe-ly Trial	2010	1K

Page 1